Today before the opening bell, International Stem Cell Corporation announced that an open letter to shareholders has been issued by Co-Chairman of the Board and Chief Executive Officer Andrey Semechkin PhD.
Addressing recent corporate governance and operational changes, the letter also provides an update on ISCO's Research and Development accomplishments, challenges and 2012 - 2013 major milestones, and updates on both the Lifeline Skin Care's and Lifeline Cell Technology's initiatives.
The letter, in its entirety, can be found at the following link: www.internationalstemcell.com/2012_Share...
For additional information on ISCO, visit the company's website at internationalstemcell.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net